type here...

CATEGORIES

Patient Zone

LATEST

1...545556...59Page 55 of 59

TRENDING

EDITORS CHOICE

Medika Welcomes Fiona O’Leary to Our Editorial Team

Robert Turner, Founding Editor -
Medika is thrilled to announce that Fiona O'Leary has joined our team. Fiona is best known for years of medical activism in the fields of autism and quackery.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Why Policymakers in Asia-Pacific Should Facilitate Digital Health Innovation

Aman Gupta -
Re-invention, re-imagination, and transformation of the health sector across the world are enabled by technological capabilities and innovation.

Drugs are Rapidly Becoming Healthcare’s Greatest Burden

Robert Turner, Founding Editor -
Drugs have become our fallback for almost everything. Practitioners in general are massively guilty of doling them out as a panacea for socially compromised adults. Adults that possess no life skills or coping mechanisms are simply drugged into oblivion.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories